Acadian Asset Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,749
| Closed | -$80K | – | 1758 |
|
|
2024
Q3 | $80K | Buy |
+2,749
| New | +$80K | ﹤0.01% | 1667 |
|
|
2022
Q1 | – | Sell |
-11,805
| Closed | -$526K | – | 1670 |
|
|
2021
Q4 | $526K | Buy |
11,805
+957
| +9% | +$42.6K | ﹤0.01% | 995 |
|
|
2021
Q3 | $547K | Sell |
10,848
-15,906
| -59% | -$802K | ﹤0.01% | 1014 |
|
|
2021
Q2 | $2.1M | Buy |
26,754
+20,817
| +351% | +$1.63M | 0.01% | 698 |
|
|
2021
Q1 | $339K | Buy |
+5,937
| New | +$339K | ﹤0.01% | 1326 |
|
|
2019
Q3 | – | Sell |
-11,650
| Closed | -$241K | – | 1902 |
|
|
2019
Q2 | $241K | Buy |
11,650
+6,728
| +137% | +$139K | ﹤0.01% | 1181 |
|
|
2019
Q1 | $114K | Buy |
+4,922
| New | +$114K | ﹤0.01% | 1481 |
|